Personal use of hormone therapy by postmenopausal women doctors and male doctors' wives in Italy after the publication of WHI trial

Nicoletta Biglia, Ester Ujcic, Franziska Kubatzki, Paola Sgandurra, Claudio Robba, Riccardo Ponzone, Piero Sismondi

Research output: Contribution to journalArticle

Abstract

Objective: To describe the prevalence of hormone replacement therapy (HT) use by postmenopausal women doctors and doctors' wives in Italy and to explore the relationship between their personal characteristics and HT use. Design: A total of 500 women doctors and 500 men doctors answering on behalf of their female partners were interviewed by a specialised company in the first months of 2003. Questions were meant to explore medical, behavioural and professional characteristics, personal use of HT, reasons for or against HT use and side effects of HT. The distribution of doctors' specialisation (general practitioners (GPs), gynaecologists, medical oncologists) in the sample interviewed was the same as that of the Italian medical community. Results: Overall, 37% of women doctors and 39% of doctors' wives had ever used HT after menopause, of which 64 and 58%, respectively, were current users. The median duration of HT in the past users was 2.7 years for women doctors and 3.7 for doctors' wives. There were wide differences of HT use according to the type of specialisation: gynaecologists were more willing to use HT (56-59%) than GPs (30-31%) or medical oncologists (16-30%).Vasomotor symptoms (68-69%), followed by the prevention of osteoporosis (28-39%), were the main reasons for commencing HT. The main reasons not to take or to stop HT were the absence or resolution of menopausal symptoms. Only 8% of women doctors and 4% doctors' wives stopped HT after the publication of the WHI data. Conclusions: In Italy, women doctors/doctors' wives personally use HT much more than postmenopausal general population.

Original languageEnglish
Pages (from-to)181-192
Number of pages12
JournalMaturitas
Volume54
Issue number2
DOIs
Publication statusPublished - May 20 2006

Fingerprint

Hormone Replacement Therapy
Spouses
Italy
Publications
Hormones
Therapeutics
General Practitioners
Estrogen Replacement Therapy
Menopause
Osteoporosis

Keywords

  • Hormone replacement therapy
  • Personal use
  • Survey
  • Women doctors

ASJC Scopus subject areas

  • Ageing
  • Obstetrics and Gynaecology

Cite this

Personal use of hormone therapy by postmenopausal women doctors and male doctors' wives in Italy after the publication of WHI trial. / Biglia, Nicoletta; Ujcic, Ester; Kubatzki, Franziska; Sgandurra, Paola; Robba, Claudio; Ponzone, Riccardo; Sismondi, Piero.

In: Maturitas, Vol. 54, No. 2, 20.05.2006, p. 181-192.

Research output: Contribution to journalArticle

@article{660b912c793f43468f8b7fc36599e1f4,
title = "Personal use of hormone therapy by postmenopausal women doctors and male doctors' wives in Italy after the publication of WHI trial",
abstract = "Objective: To describe the prevalence of hormone replacement therapy (HT) use by postmenopausal women doctors and doctors' wives in Italy and to explore the relationship between their personal characteristics and HT use. Design: A total of 500 women doctors and 500 men doctors answering on behalf of their female partners were interviewed by a specialised company in the first months of 2003. Questions were meant to explore medical, behavioural and professional characteristics, personal use of HT, reasons for or against HT use and side effects of HT. The distribution of doctors' specialisation (general practitioners (GPs), gynaecologists, medical oncologists) in the sample interviewed was the same as that of the Italian medical community. Results: Overall, 37{\%} of women doctors and 39{\%} of doctors' wives had ever used HT after menopause, of which 64 and 58{\%}, respectively, were current users. The median duration of HT in the past users was 2.7 years for women doctors and 3.7 for doctors' wives. There were wide differences of HT use according to the type of specialisation: gynaecologists were more willing to use HT (56-59{\%}) than GPs (30-31{\%}) or medical oncologists (16-30{\%}).Vasomotor symptoms (68-69{\%}), followed by the prevention of osteoporosis (28-39{\%}), were the main reasons for commencing HT. The main reasons not to take or to stop HT were the absence or resolution of menopausal symptoms. Only 8{\%} of women doctors and 4{\%} doctors' wives stopped HT after the publication of the WHI data. Conclusions: In Italy, women doctors/doctors' wives personally use HT much more than postmenopausal general population.",
keywords = "Hormone replacement therapy, Personal use, Survey, Women doctors",
author = "Nicoletta Biglia and Ester Ujcic and Franziska Kubatzki and Paola Sgandurra and Claudio Robba and Riccardo Ponzone and Piero Sismondi",
year = "2006",
month = "5",
day = "20",
doi = "10.1016/j.maturitas.2005.10.008",
language = "English",
volume = "54",
pages = "181--192",
journal = "Maturitas",
issn = "0378-5122",
publisher = "Elsevier Ireland Ltd",
number = "2",

}

TY - JOUR

T1 - Personal use of hormone therapy by postmenopausal women doctors and male doctors' wives in Italy after the publication of WHI trial

AU - Biglia, Nicoletta

AU - Ujcic, Ester

AU - Kubatzki, Franziska

AU - Sgandurra, Paola

AU - Robba, Claudio

AU - Ponzone, Riccardo

AU - Sismondi, Piero

PY - 2006/5/20

Y1 - 2006/5/20

N2 - Objective: To describe the prevalence of hormone replacement therapy (HT) use by postmenopausal women doctors and doctors' wives in Italy and to explore the relationship between their personal characteristics and HT use. Design: A total of 500 women doctors and 500 men doctors answering on behalf of their female partners were interviewed by a specialised company in the first months of 2003. Questions were meant to explore medical, behavioural and professional characteristics, personal use of HT, reasons for or against HT use and side effects of HT. The distribution of doctors' specialisation (general practitioners (GPs), gynaecologists, medical oncologists) in the sample interviewed was the same as that of the Italian medical community. Results: Overall, 37% of women doctors and 39% of doctors' wives had ever used HT after menopause, of which 64 and 58%, respectively, were current users. The median duration of HT in the past users was 2.7 years for women doctors and 3.7 for doctors' wives. There were wide differences of HT use according to the type of specialisation: gynaecologists were more willing to use HT (56-59%) than GPs (30-31%) or medical oncologists (16-30%).Vasomotor symptoms (68-69%), followed by the prevention of osteoporosis (28-39%), were the main reasons for commencing HT. The main reasons not to take or to stop HT were the absence or resolution of menopausal symptoms. Only 8% of women doctors and 4% doctors' wives stopped HT after the publication of the WHI data. Conclusions: In Italy, women doctors/doctors' wives personally use HT much more than postmenopausal general population.

AB - Objective: To describe the prevalence of hormone replacement therapy (HT) use by postmenopausal women doctors and doctors' wives in Italy and to explore the relationship between their personal characteristics and HT use. Design: A total of 500 women doctors and 500 men doctors answering on behalf of their female partners were interviewed by a specialised company in the first months of 2003. Questions were meant to explore medical, behavioural and professional characteristics, personal use of HT, reasons for or against HT use and side effects of HT. The distribution of doctors' specialisation (general practitioners (GPs), gynaecologists, medical oncologists) in the sample interviewed was the same as that of the Italian medical community. Results: Overall, 37% of women doctors and 39% of doctors' wives had ever used HT after menopause, of which 64 and 58%, respectively, were current users. The median duration of HT in the past users was 2.7 years for women doctors and 3.7 for doctors' wives. There were wide differences of HT use according to the type of specialisation: gynaecologists were more willing to use HT (56-59%) than GPs (30-31%) or medical oncologists (16-30%).Vasomotor symptoms (68-69%), followed by the prevention of osteoporosis (28-39%), were the main reasons for commencing HT. The main reasons not to take or to stop HT were the absence or resolution of menopausal symptoms. Only 8% of women doctors and 4% doctors' wives stopped HT after the publication of the WHI data. Conclusions: In Italy, women doctors/doctors' wives personally use HT much more than postmenopausal general population.

KW - Hormone replacement therapy

KW - Personal use

KW - Survey

KW - Women doctors

UR - http://www.scopus.com/inward/record.url?scp=33748062352&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33748062352&partnerID=8YFLogxK

U2 - 10.1016/j.maturitas.2005.10.008

DO - 10.1016/j.maturitas.2005.10.008

M3 - Article

C2 - 16330170

AN - SCOPUS:33748062352

VL - 54

SP - 181

EP - 192

JO - Maturitas

JF - Maturitas

SN - 0378-5122

IS - 2

ER -